CATALOGO DEI PRODOTTI DELLA RICERCA

BENEDETTI, MARIADONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.788
EU - Europa 4.950
AS - Asia 3.460
SA - Sud America 455
Continente sconosciuto - Info sul continente non disponibili 111
AF - Africa 84
OC - Oceania 12
Totale 15.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.601
RU - Federazione Russa 1.819
SG - Singapore 1.272
CN - Cina 1.217
GB - Regno Unito 1.005
IT - Italia 540
SE - Svezia 392
BR - Brasile 346
FR - Francia 282
HK - Hong Kong 270
VN - Vietnam 262
FI - Finlandia 235
DE - Germania 220
IE - Irlanda 209
KR - Corea 104
CA - Canada 85
UA - Ucraina 68
BD - Bangladesh 57
IN - India 55
TR - Turchia 40
AR - Argentina 39
JP - Giappone 33
BE - Belgio 30
MX - Messico 24
PL - Polonia 23
CR - Costa Rica 22
EC - Ecuador 21
IQ - Iraq 20
NL - Olanda 20
ZA - Sudafrica 20
ES - Italia 18
ID - Indonesia 18
IL - Israele 16
NG - Nigeria 16
SA - Arabia Saudita 15
IR - Iran 14
PY - Paraguay 14
AT - Austria 12
CL - Cile 12
UZ - Uzbekistan 12
CH - Svizzera 11
AU - Australia 10
CO - Colombia 10
CZ - Repubblica Ceca 10
MA - Marocco 9
PK - Pakistan 9
SV - El Salvador 9
DK - Danimarca 8
GR - Grecia 7
JO - Giordania 7
NI - Nicaragua 7
PR - Porto Rico 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
EU - Europa 6
LT - Lituania 6
VE - Venezuela 6
AZ - Azerbaigian 5
JM - Giamaica 5
PH - Filippine 5
RO - Romania 5
TN - Tunisia 5
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
LV - Lettonia 4
PA - Panama 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AL - Albania 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KG - Kirghizistan 3
MD - Moldavia 3
MN - Mongolia 3
OM - Oman 3
PE - Perù 3
RS - Serbia 3
SC - Seychelles 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AO - Angola 2
BO - Bolivia 2
BS - Bahamas 2
GP - Guadalupe 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
SN - Senegal 2
TG - Togo 2
UY - Uruguay 2
AD - Andorra 1
AG - Antigua e Barbuda 1
Totale 15.738
Salva come PNG Salva come JPEG
Città #
Ashburn 936
Southend 814
Singapore 710
Moscow 613
Chandler 611
San Jose 577
Dallas 477
Jacksonville 430
Woodbridge 410
Ann Arbor 301
Hong Kong 265
Dublin 209
Council Bluffs 198
Houston 195
Verona 194
Beijing 182
New York 156
The Dalles 120
Wilmington 99
Los Angeles 92
Lawrence 89
Princeton 89
Nanjing 85
Jinan 80
Helsinki 76
Hebei 74
Hanoi 65
Ho Chi Minh City 65
Shenyang 62
Santa Clara 55
Buffalo 54
São Paulo 52
Orem 48
Tianjin 45
Munich 41
Haikou 40
Changsha 39
Milan 39
Boardman 37
Ningbo 37
Columbus 34
Zhengzhou 32
Redondo Beach 30
Brussels 29
Carrboro 29
Taiyuan 28
Tokyo 28
Turku 28
Washington 28
Hangzhou 27
Lancaster 27
Nanchang 26
Taizhou 25
Fuzhou 24
Stockholm 24
Seattle 23
Bologna 22
Sindelfingen 22
Guangzhou 21
Istanbul 21
Montreal 21
Rome 21
San José 21
Atlanta 20
Brooklyn 20
Chennai 20
Redmond 20
Redwood City 20
Denver 19
Toronto 19
Jiaxing 18
Warsaw 18
Chicago 17
Frankfurt am Main 16
Norwalk 16
Abuja 15
Auburn Hills 15
Da Nang 15
London 15
Poplar 15
Falls Church 14
Lanzhou 14
Phoenix 14
San Francisco 14
Annandale 13
Boston 13
Johannesburg 13
Manchester 13
Belo Horizonte 12
Düsseldorf 12
Haiphong 12
Seoul 12
Amsterdam 11
Clearwater 11
Cleveland 11
Paris 11
Tashkent 11
Baghdad 10
Dong Ket 10
Olomouc 10
Totale 9.891
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 282
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 251
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 251
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 250
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 248
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 242
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 237
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 232
Cognitive onset in multiple sclerosis 224
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 223
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 221
A case of acute fulminant multiple sclerosis treated with alemtuzumab 221
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 220
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 219
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 217
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 217
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 216
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 216
Effects of pulsed electromagnetic fields on nerve regeneration: an experimental study in the rat 209
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 209
Apporto della neurofisiologia allo studio delle disfunzioni dell'apparato uro-genitale 206
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 204
COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk 203
Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases 201
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? 201
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 201
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 194
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 194
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 193
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population. 190
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial 190
Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immuno-cytochemical and morphometric study 189
Epilepsy in multiple sclerosis: The role of temporal lobe damage 189
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 188
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study 188
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 187
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 187
Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. 185
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 184
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 183
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 182
Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis 178
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 178
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 177
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 177
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 175
A multicentric prospective incidence study of Guillain-Barré Syndrome in Italy. The ITANG Study 175
Epilessia ed imaging 171
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 171
Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro 170
Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients. 167
Multifactorial etiological aspects of epilepsy 164
Azathioprine in multiple sclerosis 161
Prognosi del Piccolo Male-assenze tipiche. Studio di follow-up su 60 casi. [Prognosis of pure petit mal. Follow-up study of 60 cases] 160
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 160
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 160
Resting motor threshold in idiopathic generalized epilepsies: A systematic review with meta-analysis. 158
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 157
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 157
Prevalence of dementia and apoliprotein E genotype distribution in the elderly of Buttapietra, Verona Province, Italy 156
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 155
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 154
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 153
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 151
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 151
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 149
Long survival and clinical stability in Marburg's variant multiple sclerosis. 147
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 146
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis 146
Short term prognosis of stroke in a clinical series of 94 patients 144
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study 143
Prognostic factors of acute partial transverse myelitis. 142
Prognosis of Epilepsy in Newly Referred Patients: A Multicenter Prospective Study of the Effects of Monotherapy on the Long‐Term Course of Epilepsy 141
Efficacia della monoterapia in pazienti epilettici di nuova diagnosi e precedentemente non trattati. Studio prospettico 139
Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. 133
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 132
Use of plasma levels for antiepileptic drug monitoring in clinical practice 132
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study 131
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 129
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 127
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study. 127
Reappraisal of Aβ40 and Aβ42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease 120
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 119
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 118
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial 113
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 112
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. 100
Trial of minocycline in clinically isolated syndrome of Multiple Sclerosis 100
Multiple radiculopathy as the presenting manifestation of primary spinal leptomeningeal B cell lymphoma detected by flow cytometry of cerebrospinal fluid. 98
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. 96
Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis 96
Totale 15.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.590
article - articoli 50.803
book - libri 0
conference - conferenze 622
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.165
Totale 105.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022369 0 0 0 0 19 23 10 54 26 18 51 168
2022/20231.607 109 195 140 290 126 364 12 114 176 11 49 21
2023/2024860 30 72 83 85 101 195 26 78 6 33 90 61
2024/20251.832 95 128 104 288 111 71 93 72 252 97 152 369
2025/20265.945 408 266 486 920 1.574 372 531 265 511 344 91 177
2026/20271.068 53 131 274 605 5 0 0 0 0 0 0 0
Totale 15.860